Insider Sale by Lin Elizabeth Yeu (Chief Medical Officer)
Trade Summary
6 days ago, Lin Elizabeth Yeu, serving as Chief Medical Officer at Tarsus Pharmaceuticals, Inc. (TARS), sold 13,953 shares at $87.50 per share, for a total transaction value of $1,220,885.00. Following this transaction, Lin Elizabeth Yeu now holds 1,590 shares of TARS.
This sale represents a 89.77% decrease in Lin Elizabeth Yeu's stake in the company. This is considered a high-conviction trade given the significant change in ownership.
The trade was executed on Friday, September 4, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, September 9, 2026 at 4:13 PM ET, 5 days after the trade was made.
Tarsus Pharmaceuticals, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.
Trade Price
$87.50
Quantity
13,953
Total Value
$1,220,885.00
Shares Owned
1,590
Trade Date
6 days ago
SEC Filing Date
at 4:13 PM ET
Filed 5 days after trade
Discussion